Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) EPS (Basic) (2018 - 2025)

AVITA Medical (RCEL) has disclosed EPS (Basic) for 7 consecutive years, with -$0.38 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 15.56% year-over-year to -$0.38, compared with a TTM value of -$1.74 through Dec 2025, up 27.2%, and an annual FY2025 reading of -$1.74, up 27.2% over the prior year.
  • EPS (Basic) was -$0.38 for Q4 2025 at AVITA Medical, up from -$0.46 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.38 in Q1 2022 and bottomed at -$0.73 in Q1 2024.
  • Average EPS (Basic) over 4 years is -$0.31, with a median of -$0.38 recorded in 2025.
  • The sharpest move saw EPS (Basic) tumbled 254.55% in 2023, then surged 37.29% in 2025.
  • Year by year, EPS (Basic) stood at $0.22 in 2022, then tumbled by 227.27% to -$0.28 in 2023, then crashed by 60.71% to -$0.45 in 2024, then increased by 15.56% to -$0.38 in 2025.
  • Business Quant data shows EPS (Basic) for RCEL at -$0.38 in Q4 2025, -$0.46 in Q3 2025, and -$0.37 in Q2 2025.